Loading…

The cannabinoid receptors agonist WIN55212-2 inhibits macrophageal differentiation and alters expression and phosphorylation of cell cycle control proteins

In this study we investigated if and how cannabinoid receptor stimulation regulates macrophageal differentiation, which is one of the key steps in the immune effector reaction. For that reason, we used a well established differentiation model system of human U937 myelocytic leukemia cells that diffe...

Full description

Saved in:
Bibliographic Details
Main Authors: Katrin Paulsen, Svantje Tauber, Johanna Timm, Nadine Goelz, Claudia Dumrese, Alexandra Stolzing, Ralf Hass, Oliver Ullrich
Format: Default Article
Published: 2011
Subjects:
Online Access:https://hdl.handle.net/2134/16431
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1818173214222712832
author Katrin Paulsen
Svantje Tauber
Johanna Timm
Nadine Goelz
Claudia Dumrese
Alexandra Stolzing
Ralf Hass
Oliver Ullrich
author_facet Katrin Paulsen
Svantje Tauber
Johanna Timm
Nadine Goelz
Claudia Dumrese
Alexandra Stolzing
Ralf Hass
Oliver Ullrich
author_sort Katrin Paulsen (121640)
collection Figshare
description In this study we investigated if and how cannabinoid receptor stimulation regulates macrophageal differentiation, which is one of the key steps in the immune effector reaction. For that reason, we used a well established differentiation model system of human U937 myelocytic leukemia cells that differentiate along the monocyte/macrophage lineage upon stimulation with the phorbol ester PMA. Constant cannabinoid receptor (CB) stimulation was performed using WIN55212-2, a potent synthetic CB agonist. We found that WIN55212-2 inhibited CB1/2-receptor-dependent PMA-induced differentiation of human myelocytic U937 cells into the macrophageal phenotype, which was associated with impaired vimentin, ICAM-1 and CD11b expression. In the presence of WIN55212-2, cdc2 protein and mRNA expression was progressively enhanced and Tyr-15-phosporylation of cdc2 was reduced in differentiating U937 cells. Additionally, p21§ssup§Waf1/Cip1 §esup§expression was up-regulated. PMA-induced apoptosis was not enhanced by WIN55212-2 and differentiation-associated c-jun expression was not altered. In conclusion, we suppose that WIN55212-2-induced signals interferes with cell-cycle-arrest- signaling in differentiating myelocytic cells and thus inhibits macrophageal differentiation. Thus, it is possible that the cannabinoid system is able to influence one of the key steps in the immune effector function, the monocytic-macrophageal differentiation by alteration of cell cycle control proteins cdc2 and p21, and is therefore representing a promising option for therapeutic intervention in exacerbated immune reactions. © 2011 Paulsen et al; licensee BioMed Central Ltd.
format Default
Article
id rr-article-9562895
institution Loughborough University
publishDate 2011
record_format Figshare
spelling rr-article-95628952011-01-01T00:00:00Z The cannabinoid receptors agonist WIN55212-2 inhibits macrophageal differentiation and alters expression and phosphorylation of cell cycle control proteins Katrin Paulsen (121640) Svantje Tauber (121637) Johanna Timm (7212020) Nadine Goelz (7212023) Claudia Dumrese (6844) Alexandra Stolzing (1251348) Ralf Hass (283575) Oliver Ullrich (121657) Genetics not elsewhere classified Mechanical engineering not elsewhere classified Immune control Macrophages Differentiation Cannabinoids Mechanical Engineering not elsewhere classified Genetics In this study we investigated if and how cannabinoid receptor stimulation regulates macrophageal differentiation, which is one of the key steps in the immune effector reaction. For that reason, we used a well established differentiation model system of human U937 myelocytic leukemia cells that differentiate along the monocyte/macrophage lineage upon stimulation with the phorbol ester PMA. Constant cannabinoid receptor (CB) stimulation was performed using WIN55212-2, a potent synthetic CB agonist. We found that WIN55212-2 inhibited CB1/2-receptor-dependent PMA-induced differentiation of human myelocytic U937 cells into the macrophageal phenotype, which was associated with impaired vimentin, ICAM-1 and CD11b expression. In the presence of WIN55212-2, cdc2 protein and mRNA expression was progressively enhanced and Tyr-15-phosporylation of cdc2 was reduced in differentiating U937 cells. Additionally, p21§ssup§Waf1/Cip1 §esup§expression was up-regulated. PMA-induced apoptosis was not enhanced by WIN55212-2 and differentiation-associated c-jun expression was not altered. In conclusion, we suppose that WIN55212-2-induced signals interferes with cell-cycle-arrest- signaling in differentiating myelocytic cells and thus inhibits macrophageal differentiation. Thus, it is possible that the cannabinoid system is able to influence one of the key steps in the immune effector function, the monocytic-macrophageal differentiation by alteration of cell cycle control proteins cdc2 and p21, and is therefore representing a promising option for therapeutic intervention in exacerbated immune reactions. © 2011 Paulsen et al; licensee BioMed Central Ltd. 2011-01-01T00:00:00Z Text Journal contribution 2134/16431 https://figshare.com/articles/journal_contribution/The_cannabinoid_receptors_agonist_WIN55212-2_inhibits_macrophageal_differentiation_and_alters_expression_and_phosphorylation_of_cell_cycle_control_proteins/9562895 CC BY 3.0
spellingShingle Genetics not elsewhere classified
Mechanical engineering not elsewhere classified
Immune control
Macrophages
Differentiation
Cannabinoids
Mechanical Engineering not elsewhere classified
Genetics
Katrin Paulsen
Svantje Tauber
Johanna Timm
Nadine Goelz
Claudia Dumrese
Alexandra Stolzing
Ralf Hass
Oliver Ullrich
The cannabinoid receptors agonist WIN55212-2 inhibits macrophageal differentiation and alters expression and phosphorylation of cell cycle control proteins
title The cannabinoid receptors agonist WIN55212-2 inhibits macrophageal differentiation and alters expression and phosphorylation of cell cycle control proteins
title_full The cannabinoid receptors agonist WIN55212-2 inhibits macrophageal differentiation and alters expression and phosphorylation of cell cycle control proteins
title_fullStr The cannabinoid receptors agonist WIN55212-2 inhibits macrophageal differentiation and alters expression and phosphorylation of cell cycle control proteins
title_full_unstemmed The cannabinoid receptors agonist WIN55212-2 inhibits macrophageal differentiation and alters expression and phosphorylation of cell cycle control proteins
title_short The cannabinoid receptors agonist WIN55212-2 inhibits macrophageal differentiation and alters expression and phosphorylation of cell cycle control proteins
title_sort cannabinoid receptors agonist win55212-2 inhibits macrophageal differentiation and alters expression and phosphorylation of cell cycle control proteins
topic Genetics not elsewhere classified
Mechanical engineering not elsewhere classified
Immune control
Macrophages
Differentiation
Cannabinoids
Mechanical Engineering not elsewhere classified
Genetics
url https://hdl.handle.net/2134/16431